acute COVID-19
[용어속성] Disease
Caring for older adults during the COVID-19 pandemic
Review article
[키워드] acute COVID-19
age
Atypical
booster dose
Care
Characteristics
clinical
cognitive
Comorbidities
conducted
content
contribute
contributing to
COVID
COVID-19
COVID-19 pandemic
database
death
delirium
Diagnosis
Efficacy
effort
elderly
Elderly patient
Evidence
exclusion
Factor
Factors
Fatality rate
Fever
frailty
functional
geriatric
high risk
highlight
increased risk
increasingly
intensive care
key factor
literature review
Long COVID
management
Mortality
neurological manifestation
objective
Older
outcome
Patient
patients with COVID-19
predict
question
reported
Research
risk
SARS-CoV-2
selected
Source
survived
the MEDLINE
unmet need
Vaccine
Vaccines
was performed
with COVID-19
[DOI] 10.1016/j.cmi.2022.02.040 [Article Type] Review article
[DOI] 10.1016/j.cmi.2022.02.040 [Article Type] Review article
SARS CoV-2 (Delta Variant) Infection Kinetics and Immunopathogenesis in Domestic Cats
SARS CoV-2(Delta Variant) 감염 역학 및 국내 고양이의 면역 병인 발생
Article
[키워드] ACE2-expressing cell
ACE2-expressing cells
acute COVID-19
acute infection
animal model
animal models
B.1.617.2
chemokine
chemokine signaling
circulating
Clinical sign
Cluster
correlated
correlation
COVID-19 disease
COVID-19 disease course
Critical
cytokine receptor
Delta
delta variant
develop
differentially expressed gene
Differentially expressed genes
disease
Disease progression
disease transmission
Divergence
domestic cats
dose
downstream
dysregulated
evaluate
feline
ferrets
flexible
genetic modification
help
highlight
Host
hub genes
identify
immunopathology
include
Infection
Infectious virus
Inflammatory
inflammatory pathways
inoculated
Interaction
interactions
intranasally
Kinetics
lesion
lesions
limitation
lung
lung tissue
Lungs
Mild
nasal
network analysis
non-human primates
pathology
pathway
peribronchial
Pneumocytes
Post-infection
Prevent
progression
pulmonary inflammation
pulmonary lesion
pulmonary lesions
Respiratory disease
RNA sequencing
SARS CoV
SARS CoV-2
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 variant
SARS-CoV-2 variants
secretion
significantly
Spread
target
therapeutic
timepoints
transgenic mice
translational
upregulation
variant
Vascular endothelium
Vasculitis
Viral antigen
Viral protein
virus
WGCNA
wild-type SARS-CoV-2
[DOI] 10.3390/v14061207 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/v14061207 PMC 바로가기 [Article Type] Article
Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort
Observational Study
[키워드] 95% CI
acute COVID-19
Anosmia
association
baseline
BMI
Clinical characteristics
clinical factor
clinical symptom
Cohort
conducted
COVID-19
COVID-19 infection
death
demographic
development
diabete
evaluate
Factor
fatigue
Follow-up
functional
greater
hospital discharge
Hospitalized
hospitalized patient
incidence
index
Infection
information
Inpatient
laboratory-confirmed
Medicaid
Odds ratio
Older age
older patients
Organ transplant
Outpatient
outpatients
PASC
Patient
Population
Prospective
questionnaire
risk factor
risk of death
SARS-CoV-2
setting
Shortness of breath
subset
survivor
Symptom
symptomatic
USA
vulnerability
while
with COVID-19
[DOI] 10.1007/s11606-022-07523-3 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1007/s11606-022-07523-3 PMC 바로가기 [Article Type] Observational Study
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19
인터페론 경로 루푸스 위험 대립 유전자는 급성 COVID-19로 인한 사망 위험을 조절합니다
Article
Published on
Journal: Translational research : the journal of laboratory [Category] 바이오마커, 변종, 유전자 메커니즘, 치료제,
Journal: Translational research : the journal of laboratory [Category] 바이오마커, 변종, 유전자 메커니즘, 치료제,
[키워드] Activation
activator
acute COVID-19
age
allele
alleles
analyzed
antiviral immunity
Biomarker
Blood
BMI = body mass index
body mass
body mass index
C-reactive protein
cGMP
contribute
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 = coronavirus disease 2019
Critical
CRP = C-reactive protein
D-dimer
death
Defense
disease
domain
Effect
gain-of-function
Genetic
genetic information
genetic risk factor
Genotype
groups
Haplotype
Helicase
high risk
idea
IFIH1
IFIH1 = interferon-induced with helicase c domain 1
IFN
IFN = interferon
IFN pathway
Increased
interferon
interferon regulatory factor
IRF = interferon regulatory factor
IRF5
IRF7
IRF8
lupus erythematosus
modulate
Mortality
nucleotide
NYU = New York University
older subjects
OR = odds ratio
pathway
Patient
positive
Predictive
Primary outcome
PRKG1
PRKG1 = protein kinase cGMP-dependent 1
protective effect
Protective effects
Protein
protein kinase
Regulatory
risk
risk allele
risk factor
risk of death
significantly
Single nucleotide polymorphism
SLE
SLE = systemic lupus erythematosus
SNP = single nucleotide polymorphism
STAT4
STAT4 = signal transducer and activator of transcription 4.
subjects
Support
systemic lupus erythematosus
Transcription
troponin
Type
Type I IFN
type I interferon
variants
viral infections
York
younger patient
younger patients
[DOI] 10.1016/j.trsl.2022.01.007 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.trsl.2022.01.007 PMC 바로가기 [Article Type] Article
An overview of COVID-19 in solid organ transplantation
Review article
Published on
Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 변종,
Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 변종,
[키워드] acute COVID-19
anti-inflammatory treatment
Antiviral
approach
article
candidate
Case series
changes in
Contact
content
Course
COVID-19
COVID-19 infection
COVID-19 pandemic
defined
Donor
Donor selection
Donor-derived infections
evaluated
feasible
General population
Google Scholar
hygiene
Impact
increasingly
Infection
Intervention
Lung disease
lung transplant
Mortality
notable
objective
occur
other organ
outcomes
PCR-positive
performed
physical distancing
prevention
prevention of COVID-19
recipient
recipients
SARS-CoV-2
SARS-COV-2 infection
searched
solid organ transplantation
solid organ transplants
SOT
Source
These data
Transplant candidates
transplantation
Treatment
vaccination
Volume
Web of Science
[DOI] 10.1016/j.cmi.2022.02.005 [Article Type] Review article
[DOI] 10.1016/j.cmi.2022.02.005 [Article Type] Review article
SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19
코로나19 신경 유래 엑소좀의 SARS-CoV-2 및 미토콘드리아 단백질
Article
[키워드] 12S rRNA
acute COVID-19
anion
ANN
Astrocyte
Biomarker
Biomarkers
calcium
calcium channel
CD81
Cell
Central nervous system
Complex I
complex III
controls
COVID-19
Exosome
extracellular vesicle
Extracellular vesicles
Frame
healthy controls
Human
Humanin
LETM1
leucine
long-COVID
manifestation
marker
MCU
mechanism
Mitochondria
mitochondrial
N-methyl-D-aspartate
N-methyl-D-aspartate receptor
Neuropsychiatric
nucleocapsid
PASC
plasma
Protein
quantified
resolved
respiratory chain
S1 protein
SARS-CoV-2
SARS-CoV-2 N
SARS-CoV-2 protein
SARS-CoV-2 proteins
SARS-CoV-2 S1
significantly
sodium
subunit
therapeutic
therapeutic trials
transmembrane
trials
VDAC1
was used
[DOI] 10.1002/ana.26350 PMC 바로가기 [Article Type] Article
[DOI] 10.1002/ana.26350 PMC 바로가기 [Article Type] Article
Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study
Post-COVID-19 증후군, 저등급 염증 및 염증 표지자: 단면 연구
Article
[키워드] acute COVID-19
acute phase
affected
age
Ageusia
analysed
Analysis
Anosmia
association
available data
best
Biomarker
Biomarkers
BMI
C-reactive protein
collected
Community
community setting
Comorbidities
correlation
COVID-19
COVID-19 case
cross-sectional
cross-sectional study
CRP
D-dimer level
D-dimer levels
defined
develop
distributions
Dyspnea
Elevation
epidemiological data
fatigue
ferritin
fibrinogen
Fibrinogen levels
Frequency
highest
identify
increased risk
Infection
Inflammatory
inflammatory markers
Laboratory
Laboratory test
Lactate
lactate dehydrogenase
low-grade inflammation
lymphocyte
lymphocyte counts
marker
men
Mild
mild COVID-19.
multivariable analysis
multivariate
multivariate analyses
myalgia
neutrophil
neutrophil count
neutrophil counts
neutrophil/lymphocyte ratio
NLR
pathophysiological mechanism
performed
post-COVID syndrome
prevalent
reported symptom
selected
serum C-reactive protein
Sex
Sex difference
Signs and symptoms
smoking
subject
Symptom
Symptoms
syndrome
the median
variable
with COVID-19
woman
women
[DOI] 10.1080/03007995.2022.2042991 PMC 바로가기 [Article Type] Article
[DOI] 10.1080/03007995.2022.2042991 PMC 바로가기 [Article Type] Article
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
SARS-CoV-2 오미크론 변이체에 대한 교차 반응성 면역은 이전에 COVID-19 또는 MIS-C가 있는 소아 환자에서 낮습니다.
Article
[키워드] acute COVID-19
age
Alpha
Analysis
antibody
Antibody titers
Beta
children
clinical disease
Cohort
convalescent
COVID-19
cross-neutralization
Delta
demonstrated
evaluated
expected
Gamma
Hospitalized
Immunity
less
Mild
MIS-C
neutralization
neutralization capacity
neutralization titer
Neutralizing antibodies
neutralizing antibody
Neutralizing antibody titer
neutralizing antibody titers
neutralizing capacity
omicron
Omicron variants
outcome
Outpatient
outpatients
Patient
patients
pediatric
Pediatric patient
Re-infection
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 variant
SARS-CoV-2 variants
Support
the SARS-CoV-2
Transmission
vaccination
variant
variants
virus-neutralizing
[DOI] 10.1038/s41467-022-30649-1 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41467-022-30649-1 PMC 바로가기 [Article Type] Article
Post-COVID-19 Fatigue and SARS-CoV-2 Specific Humoral and T-Cell Responses in Male and Female Outpatients
남성 및 여성 외래 환자의 코로나19 이후 피로 및 SARS-CoV-2 특정 체액 및 T-세포 반응
Article
[키워드] acute COVID-19
acute infection
Analysis
assessment
both sexes
Clinical characteristics
conducted
Course
COVID-19
development
disease
ELISA
ELISPOT
enzyme-linked immunosorbent
evaluate
Ex vivo
examined
fatigue
female
Germany
humoral
IFN-γ
IFNγ
IgG antibody
IL-2
individual
Inflammation
interferon-γ
Level
male
median time
men
mild infection
not differ
Outpatient
outpatients
participant
pathophysiological mechanism
producing
response
SARS-CoV-2
SARS-CoV-2-specific T-cell response
scale
Serum level
significantly
significantly lower
Specific
suffered
T-cell
T-cell Response
T-cells
treated
university
were measured
women
[DOI] 10.3389/fimmu.2022.902140 PMC 바로가기 [Article Type] Article
[DOI] 10.3389/fimmu.2022.902140 PMC 바로가기 [Article Type] Article